Compare $MNPR vs $PBYI | Chartloom

Compare

$MNPR vs $PBYI

Monopar Therapeutics Inc · Puma Biotechnology Inc

MNPR

Monopar Therapeutics Inc

PBYI

Puma Biotechnology Inc

Compare $MNPR vs $PBYI

Comparing Monopar Therapeutics Inc and Puma Biotechnology Inc

MNPRMonopar Therapeutics Inc

PBYIPuma Biotechnology Inc

MNPRMonopar Therapeutics Inc

Market cap

$529M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

48.37x

Rev growth (TTM)

—

YTD performance

19.6%

52W performance

-19.9%

FCF yield

-2.3%

PBYIPuma Biotechnology Inc

Market cap

$524M

P/E (TTM)

20.26x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-2.9%

YTD performance

78.3%

52W performance

96.7%

FCF yield

7.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MNPR

PBYI

Detailed metrics comparison

MNPR

Monopar Therapeutics Inc

PBYI

Puma Biotechnology Inc

Market Cap

MNPR$529M

PBYI$524M

Enterprise Value

MNPR$476M

PBYI$487M

Price

MNPR$78.96

PBYI$10.29

P/E Ratio

MNPRN/A

PBYI20.26x

P/S Ratio

MNPR0.00x

PBYI2.26x

EV/Sales

MNPR0.00x

PBYI2.11x

EV/EBITDA

MNPR0.00x

PBYI10.51x

P/B Ratio

MNPR4.00x

PBYI3.54x

P/FCF Ratio

MNPRN/A

PBYI12.75x

EV/FCF

MNPR-39.10x

PBYI11.86x

PEG Ratio

MNPRN/A

PBYIN/A

Forward P/E (NTM)

MNPRN/A

PBYIN/A

Forward P/S (NTM)

MNPR48.37x

PBYIN/A

Revenue (TTM)

MNPR$0

PBYI$231M

Revenue Growth (YoY)

MNPRN/A

PBYI-2.9%

Forward Rev Growth

MNPR327.6%

PBYI-1.4%

Gross Margin (TTM)

MNPR0.0%

PBYI74.8%

Operating Margin (TTM)

MNPR0.0%

PBYI13.2%

EBITDA Margin (TTM)

MNPR0.0%

PBYI17.7%

Net Margin (TTM)

MNPR0.0%

PBYI11.6%

FCF Margin (TTM)

MNPRN/A

PBYI17.8%

Net Income (TTM)

MNPR$-18M

PBYI$27M

FCF (TTM)

MNPR$-12M

PBYI$41M

EPS (TTM)

MNPR-$2.09

PBYI$0.51

ROE (TTM)

MNPR-1308.0%

PBYI20.8%

ROA (TTM)

MNPR-1279.0%

PBYI13.3%

ROIC (TTM)

MNPR-1308.0%

PBYI18.4%

Cash

MNPR$53M

PBYI$37M

Debt

MNPR$0

PBYI$0

Net Cash/Debt

MNPR$53M

PBYI$37M

Current Ratio (TTM)

MNPR33.56x

PBYI2.91x

Quick Ratio (TTM)

MNPR33.56x

PBYI2.57x

Debt/Equity (TTM)

MNPR0.00x

PBYI0.17x

Debt/Assets (TTM)

MNPR0.0%

PBYI0.0%

Interest Coverage (TTM)

MNPRN/A

PBYIN/A

Net Debt/EBITDA (TTM)

MNPR0.00x

PBYI0.00x

Beta

MNPR1.54

PBYI1.36

52W Performance

MNPR-19.9%

PBYI96.7%

YTD Performance

MNPR19.6%

PBYI78.3%

% from 52W High

MNPR-36.7%

PBYI-0.8%

% from 52W Low

MNPR57.7%

PBYI124.7%

Asset Turnover (TTM)

MNPR0.00x

PBYI1.15x

FCF Yield (TTM)

MNPR-2.3%

PBYI7.8%

Earnings Yield (TTM)

MNPR-3.4%

PBYI5.1%

Dividend Yield (TTM)

MNPRN/A

PBYIN/A

Rule of 40

MNPR0.0

PBYI14.9

EV/GP/RG

MNPRN/A

PBYIN/A

Ticker research

View MNPR research View PBYI research

Metric	MNPR Monopar Therapeutics Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$529M	$524M
Enterprise Value	$476M	$487M
Price	$78.96	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	0.00x	2.26x
EV/Sales	0.00x	2.11x
EV/EBITDA	0.00x	10.51x
P/B Ratio	4.00x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-39.10x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	48.37x	N/A
Revenue & Growth
Revenue (TTM)	$0	$231M
Revenue Growth (YoY)	N/A	-2.9%
Forward Rev Growth	327.6%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	0.0%	17.7%
Net Margin (TTM)	0.0%	11.6%
FCF Margin (TTM)	N/A	17.8%
Net Income (TTM)	$-18M	$27M
FCF (TTM)	$-12M	$41M
EPS (TTM)	-$2.09	$0.51
ROE (TTM)	-1308.0%	20.8%
ROA (TTM)	-1279.0%	13.3%
ROIC (TTM)	-1308.0%	18.4%
Financial Health
Cash	$53M	$37M
Debt	$0	$0
Net Cash/Debt	$53M	$37M
Current Ratio (TTM)	33.56x	2.91x
Quick Ratio (TTM)	33.56x	2.57x
Debt/Equity (TTM)	0.00x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	1.36
52W Performance	-19.9%	96.7%
YTD Performance	19.6%	78.3%
% from 52W High	-36.7%	-0.8%
% from 52W Low	57.7%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.15x
FCF Yield (TTM)	-2.3%	7.8%
Earnings Yield (TTM)	-3.4%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	14.9
EV/GP/RG	N/A	N/A
Ticker research	View MNPR research	View PBYI research

Valuation

P/E Ratio

PBYI

20.26x

P/S Ratio

MNPR

0.00x

PBYI

2.26x

EV/FCF

MNPR

-39.10x

PBYI

11.86x

Growth & revenue

Revenue Growth TTM

PBYI

-2.9%

Forward Revenue Growth

MNPR

327.6%

PBYI

-1.4%

Profitability & performance

Gross Margin

PBYI

74.8%

MNPR

0.0%

ROE

PBYI

20.8%

MNPR

-1308.0%

FCF Yield %

PBYI

7.8%

MNPR

-2.3%

52-Week Performance

PBYI

96.7%

MNPR

-19.9%

Detailed metrics comparison

MNPR

Monopar Therapeutics Inc

PBYI

Puma Biotechnology Inc

Market Cap

MNPR$529M

PBYI$524M

Enterprise Value

MNPR$476M

PBYI$487M

Price

MNPR$78.96

PBYI$10.29

P/E Ratio

MNPRN/A

PBYI20.26x

P/S Ratio

MNPR0.00x

PBYI2.26x

EV/Sales

MNPR0.00x

PBYI2.11x

EV/EBITDA

MNPR0.00x

PBYI10.51x

P/B Ratio

MNPR4.00x

PBYI3.54x

P/FCF Ratio

MNPRN/A

PBYI12.75x

EV/FCF

MNPR-39.10x

PBYI11.86x

PEG Ratio

MNPRN/A

PBYIN/A

Forward P/E (NTM)

MNPRN/A

PBYIN/A

Forward P/S (NTM)

MNPR48.37x

PBYIN/A

Revenue (TTM)

MNPR$0

PBYI$231M

Revenue Growth (YoY)

MNPRN/A

PBYI-2.9%

Forward Rev Growth

MNPR327.6%

PBYI-1.4%

Gross Margin (TTM)

MNPR0.0%

PBYI74.8%

Operating Margin (TTM)

MNPR0.0%

PBYI13.2%

EBITDA Margin (TTM)

MNPR0.0%

PBYI17.7%

Net Margin (TTM)

MNPR0.0%

PBYI11.6%

FCF Margin (TTM)

MNPRN/A

PBYI17.8%

Net Income (TTM)

MNPR$-18M

PBYI$27M

FCF (TTM)

MNPR$-12M

PBYI$41M

EPS (TTM)

MNPR-$2.09

PBYI$0.51

ROE (TTM)

MNPR-1308.0%

PBYI20.8%

ROA (TTM)

MNPR-1279.0%

PBYI13.3%

ROIC (TTM)

MNPR-1308.0%

PBYI18.4%

Cash

MNPR$53M

PBYI$37M

Debt

MNPR$0

PBYI$0

Net Cash/Debt

MNPR$53M

PBYI$37M

Current Ratio (TTM)

MNPR33.56x

PBYI2.91x

Quick Ratio (TTM)

MNPR33.56x

PBYI2.57x

Debt/Equity (TTM)

MNPR0.00x

PBYI0.17x

Debt/Assets (TTM)

MNPR0.0%

PBYI0.0%

Interest Coverage (TTM)

MNPRN/A

PBYIN/A

Net Debt/EBITDA (TTM)

MNPR0.00x

PBYI0.00x

Beta

MNPR1.54

PBYI1.36

52W Performance

MNPR-19.9%

PBYI96.7%

YTD Performance

MNPR19.6%

PBYI78.3%

% from 52W High

MNPR-36.7%

PBYI-0.8%

% from 52W Low

MNPR57.7%

PBYI124.7%

Asset Turnover (TTM)

MNPR0.00x

PBYI1.15x

FCF Yield (TTM)

MNPR-2.3%

PBYI7.8%

Earnings Yield (TTM)

MNPR-3.4%

PBYI5.1%

Dividend Yield (TTM)

MNPRN/A

PBYIN/A

Rule of 40

MNPR0.0

PBYI14.9

EV/GP/RG

MNPRN/A

PBYIN/A

Ticker research

View MNPR research View PBYI research

Metric	MNPR Monopar Therapeutics Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$529M	$524M
Enterprise Value	$476M	$487M
Price	$78.96	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	0.00x	2.26x
EV/Sales	0.00x	2.11x
EV/EBITDA	0.00x	10.51x
P/B Ratio	4.00x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-39.10x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	48.37x	N/A
Revenue & Growth
Revenue (TTM)	$0	$231M
Revenue Growth (YoY)	N/A	-2.9%
Forward Rev Growth	327.6%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	0.0%	17.7%
Net Margin (TTM)	0.0%	11.6%
FCF Margin (TTM)	N/A	17.8%
Net Income (TTM)	$-18M	$27M
FCF (TTM)	$-12M	$41M
EPS (TTM)	-$2.09	$0.51
ROE (TTM)	-1308.0%	20.8%
ROA (TTM)	-1279.0%	13.3%
ROIC (TTM)	-1308.0%	18.4%
Financial Health
Cash	$53M	$37M
Debt	$0	$0
Net Cash/Debt	$53M	$37M
Current Ratio (TTM)	33.56x	2.91x
Quick Ratio (TTM)	33.56x	2.57x
Debt/Equity (TTM)	0.00x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	1.36
52W Performance	-19.9%	96.7%
YTD Performance	19.6%	78.3%
% from 52W High	-36.7%	-0.8%
% from 52W Low	57.7%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.15x
FCF Yield (TTM)	-2.3%	7.8%
Earnings Yield (TTM)	-3.4%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	14.9
EV/GP/RG	N/A	N/A
Ticker research	View MNPR research	View PBYI research